Home
/
Bristol-Myers Squibb Company Financials
/
Bristol-Myers Squibb Company Operating Cash Flow History
Bristol-Myers Squibb Company (BMY) Operating Cash Flow History
| Quarter End | Operating Cash Flow
$ 000,000's
|
|---|---|
| 2023-Dec-31 | 4,252 |
| 2023-Sep-30 | 4,751 |
| 2023-Jun-30 | 1,887 |
| 2023-Mar-31 | 2,970 |
| 2022-Dec-31 | 3,306 |
| 2022-Sep-30 | 3,687 |
| 2022-Jun-30 | 2,261 |
| 2022-Mar-31 | 3,812 |
| 2021-Dec-31 | 4,057 |
| 2021-Sep-30 | 5,266 |
| 2021-Jun-30 | 3,060 |
| 2021-Mar-31 | 3,824 |
| 2020-Dec-31 | 3,670 |
| 2020-Sep-30 | 2,219 |
| 2020-Jun-30 | 4,269 |
Full historical financial data for Bristol-Myers Squibb Company for 1987 - 2023 is included in the
US Historical Financials dataset.